Prolactin in headache and migraine: A systematic review of clinical studies
Cephalalgia · 2023-02 · 43 (2)
DOI: 10.1177/03331024221136286 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cephalalgia, online erschienen am 30.01.2023. Verfasst von Mohammad Al-Mahdi Al-Karagholi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Danish Headache Center, Department of Neurology, Rigshospitalet- Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup…. Hauptthemen laut MEDLINE: Prolactinoma, Migraine Disorders, Hyperprolactinemia, Pituitary Neoplasms. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To systemically review clinical studies investigating the role of prolactin and its receptors in headache and migraine.
Background
Migraine prevalence is more common in women compared to men. As prolactin is a crucial regulator of the hypothalamus-pituitary-gonadal axis, prolactin and its receptors might contribute to signaling mechanisms underlying migraine.
Methods
In this systematic review, we searched PubMed and EMBASE with the terms: prolactin, hyperprolactinemia, macroprolactinemia, hypoprolactinemia, migraine, headache, head pain and trigeminal pain pathway for clinical studies investigating prolactin signaling in headache and migraine. Two reviewers independently screened 841 articles for population, intervention, comparison, outcome, and study design. Studies were restricted to the English language and were excluded if they had a nonexperimental methodology.
Results
Nineteen clinical studies met the inclusion criteria and were included in the qualitative and quantitative analysis. The main findings were that serum prolactin levels were found to be higher in individuals with migraine compared to healthy controls, and prolactinomas (prolactin-secreting pituitary adenomas) were correlated with higher incidence of headache in otherwise healthy individuals and migraine attacks in individuals with migraine.
Conclusion
Considerable evidence suggests a key role of prolactin and its receptors in migraine pathophysiology. Further randomized and placebo-controlled clinical studies targeting prolactin signaling are needed to further clarify influences of prolactin in migraine attack initiation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Danish Headache Center, Department of Neurology, Rigshospitalet- Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
- School of Behavioral and Brain Sciences, Center for Advanced Pain Studies, The University of Texas at Dallas, Richardson, USA.
- Danish Headache Knowledge Center on Headache Disorders, Rigshospitalet - Glostrup, Glostrup, Denmark.
ORCID-Profile: Mohammad Al-Mahdi Al-Karagholi, Veberka Kalatharan
Zitieren
APA
Al-Karagholi, M. A., Kalatharan, V., Ghanizada, H., Gram, C., Dussor, G., & Ashina, M. (2023). Prolactin in headache and migraine: A systematic review of clinical studies. Cephalalgia, 43(2). https://doi.org/10.1177/03331024221136286
Vancouver
Al-Karagholi MA, Kalatharan V, Ghanizada H, Gram C, Dussor G, Ashina M. Prolactin in headache and migraine: A systematic review of clinical studies. Cephalalgia. 2023;43(2). doi:10.1177/03331024221136286
BibTeX
@article{AlKaragholi2023,
author = {Al-Karagholi, Mohammad Al-Mahdi and Kalatharan, Veberka and Ghanizada, Hashmat and Gram, Christian and Dussor, Gregory and Ashina, Messoud},
title = {Prolactin in headache and migraine: A systematic review of clinical studies},
journal = {Cephalalgia},
year = {2023},
volume = {43},
number = {2},
doi = {10.1177/03331024221136286}
}
EUVIMED